FDA Adverse Event
Injury
Summary report: N
RELIZORB CARTRIDGE
MDR report key: 9335114
·
Received November 15, 2019
Report
- Report Number
- MW5091135
- Event Type
- Injury
- Date Received
- November 15, 2019
- Report Date
- November 14, 2019
- Manufacturer
- ALCRESTA THERAPEUTICS INC.
- Product Code
- PLQ
- UDI-DI
- 62205000020
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
Description of Event or Problem · 1
ON (B)(6) 2019 PT (B)(6) STATES SHE WAS HOSPITALIZED 2 WEEKS AGO FOR RESPIRATORY ISSUES. EVENT ONGOING. UNK USE 1 CARTRIDGE IN-LINE WITH ENTERAL FEEDING TUBE SET AS DIRECTED. CHANGE CARTRIDGE EVERY 500ML OF ENTERAL FORMULA. (MAXIMUM OF 2 CARTRIDGES USED DAILY).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1120398 | RELIZORB CARTRIDGE | ENZYME PACKED CARTRIDGE | PLQ | ALCRESTA THERAPEUTICS INC. | 62205000020 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization |